News and Events

NEW YORK, June 10th, 2010 - OneMedPlace announced today that over 70 emerging growth biotech, medtech, healthcare IT, and healthcare services companies have been confirmed to present at the quickly approaching summer finance OneMedForum, being held in New York City on June 29th and 30th.

Companies invited by the Forum's Advisory Board are considered to posses breakthrough technologies based on strong science, experienced and well-rounded management teams with a proven track record, strong and comprehensive IP portfolios, and partnerships with leading academic institutions and strategic players.

Companies presenting as of June 10th include: Abviva, Access Pharmaceuticals, AcuMEMS, AMT, AntriaBio, Arstasis, Axial Biotech, Biomoda, BioNanomatrix, Biovista Inc., The Brain Resources Company, BVH Bio, Caleco Pharma Corp., Calibra Medical, Cardiogenesis Corporation, CeQur, CyberHeart Incorporated, Cytochroma Inc., DARA BioSciences, DataPhysics Research, DATATRAK International, DermDx, DiFUSION Technologies Inc., Echo Therapeutics, Edge Therapeutics, Eleison Pharmaceuticals, EpiCept Corporation, Exact Cost, Facet Solutions, Flexible Stenting Solutions, Health Integrated, HiLin Life Products, Insite Medical, LL Tech, Lucid, MacuCLEAR Inc., MedicaSafe, Morris Innovative Research, Myconostica, Nanobiotix, NeoMatrix, NewCardio, NuVue Therapeutics, PAION, Pbio, PDS Biotechnology Co., PearlDiver, Pressure BioSciences, Principio, Inc., QuantRX Biomedical, RepRegen Ltd., S.E.A. Medical Systems, Silver Bullet Therapeutics, Sound Surgical Technologies LLC, T2 Biosystems, Tagent, Transdel Pharmaceuticals, Trigeminal Solutions, Unity Medical, Urologix, Urovalve, USHIFU LLC, Vasonova, Vaxin, VetCentric, Virtual Medical Centre, Viva, Vyteris Inc., Xlumena and Your Nurse Is On.

"The idea of an annual summit in New York City where the most promising and less-known companies can present to an audience of investors has been well received. The primary theme of the conference is accessing alternative sources of capital and New York City represents the ideal venue for this event, as it remains the global capital of finance and thus can attract investors and companies from around the world," said Brett Johnson, CEO OneMedPlace. "We believe that the next ten years will be a period of unprecedented change and disruption in health care delivery, without which the system can only collapse. This displacement represents an historic opportunity for savvy companies, entrepreneurs, and investors. The OneMedForum can help companies and investors alike prepare for the future by gaining exposure to the disruptive innovations on the horizon," added Johnson.

The conference will run an opening panel on "Accessing New Sources of Capital" that will look at how Global economic changes coupled with healthcare reform in the US is reshaping investor focus and liquidity for investment in emerging healthcare and life science companies. A diverse group of investors with transatlantic deal experience will provide insight into the sectors most impacted by these global changes. Additionally, a special panel session on Consumer-Directed Health Care and Health Savings Accounts will examine how improvements to the customer experience could offer a viable solution to the spiraling cost of America's HealthCare. Numerous workshops on topics specific to those building healthcare companies will also be presented.

For more information on the conference, visit www.onemedplace.com/forum.

About OneMedPlace: OneMedPlace is a virtual community that connects emerging companies seeking capital, distribution, and visibility, with investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize. Follow us on Twitter, Facebook and LinkedIn.

On May 12, 2010, S.E.A. Medical Systems will participate in an online conference highlighting the most promising emerging medical technology companies. The EMT (Emerging Medical Technologies)™ in the Spotlight events provide detailed information on a select group of privately-held medtech companies who are aiming to disrupt markets, find strategic partners, or raise capital. It is hosted by Life Science Intelligence (LSI) and sponsored by Rutan, Orange Coast Medical Ventures, and Medical Capital Advisors.

In a story on IV drug safety which appeared yesterday in a OneMedSentinel post: Medication Mistakes Can Be Deadly But Preventable. S.E.A. Medical was featured and progress with the pharmacy and bedside systems was reported. OneMedSentinel is a weekly E-newsletter of developments in health and medicine. It is published by OneMedPlace (OMP) a New York based healthcare research and media company. They globally connect investors and strategic partners to emerging healthcare and life science companies with strategically developed messages, integrated multimedia tools and targeted distribution. S.E.A. Medical presented at two OneMedPlace events in January of this year.

President and CEO Michael Weickert will present S.E.A. Medical Systems' innovative Smart IV technology and systems for IV drug safety on April 7 at the BayBIO 2010 conference at the Hyatt Regency hotel in Burlingame, California. BayBio2010 is a one-day conference focusing on Northern California's strength in life sciences innovation. This conference will examine the fundamental questions of who pays for biotech innovation and why in this unprecedented environment. It will focus on how the current financing environment and new sources of capital affect business models, development and commercialization strategies.

The Company Presentations Track will feature 15-minute presentations by the twelve hottest life sciences companies from early stage to series C, carefully selected by the BayBio2010 Company Presentations Advisory Board. S.E.A. Medical will have the opportunity to introduce the company, highlight key technologies, alliances, and where we stand with product developments. Public and private equity investors, research analysts and investment bankers focused on investment in the life sciences sector will be in attendance.

Starting in November, S.E.A. Medical's unique sensor chips and device prototype were used in several hospital pharmacies to test 30 "high alert" IV medications including narcotics and cytotoxics. The results were outstanding: each drug and dose produced a remarkably unique and distinct signature. On January 12, 2010, Dr. Michael J. Weickert, President and CEO of S.E.A. Medical Systems, will report the IV drug detection results from the Smart IV prototype at two meetings: Biotech Showcase and OneMedForum. Both are held in parallel with JP Morgan week in San Francisco, the largest gathering of healthcare executives and financiers in the world.

The Biotech Showcase™ will take place January 12-13, 2010 at the Marines Memorial Club & Hotel in San Francisco. Michael J. Weickert, Ph.D., President and CEO of S.E.A. Medical, will present at 8:40 am on January 12th. Conference details.

About the Biotech Showcase™ (Innovation - Opportunity - Collaboration):

Now in its second year, the Biotech Showcase™ will feature corporate presentations by 100+ innovative life science companies to an audience of public and private investors, business development executives and professional advisors who are interested in investment opportunities and collaboration. The showcase takes place during the week of one of the most important healthcare investor conferences which annually attracts thousands of healthcare and life science business executives to San Francisco in a venue located close to the center of action. To maximize efficiency, all showcase participants can schedule one-on-one meetings through the organizer's online system, partneringONE™. Public and private investors are always invited to attend the showcase on a complimentary basis. The Biotech Showcase™ was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life sciences industry.

The 3nd Annual OneMedForum will take place January 12th,13th, and 14th at the Sir Francis Drake Hotel at 450 Powell Street in San Francisco during the healthcare finance community's largest gathering of the year. The Forum provides an opportunity for the most promising emerging healthcare and life science companies to present and interact with a diverse group of global investors and partners. Michael J. Weickert, Ph.D., President and CEO of S.E.A. Medical, will present at 1:40 pm on January 12th. Conference details.

Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19. IN3 Medical Device Summit was attended by more than 250 registered guests, including venture capitalists and medtech business-development executives.

S.E.A. Medical was one of 50 emerging medical technology companies seeking funding and/or strategic partnerships presenting at the conference. President and CEO Michael Weickert, Ph.D. described S.E.A. Medical Systems' innovative Smart IV drug safety technology and products in development on October 20. The In3 Medical Device Summit is the most important venue of its kind for previewing cutting-edge emerging medical technology companies and for engaging with the biggest dealmakers in the industry, including senior executives from the device industry and healthcare investment community. The conference included a mix of presentations, speakers, roundtables, workshops and panels addressing the hottest topics in the ever-more competitive and lucrative medical technology marketplace. S.E.A. Medical Systems was very pleased to be presenting at this premier investment conference which offers us an unmatched opportunity for dozens of ideal investor interactions.

President and CEO Michael Weickert will present S.E.A. Medical Systems' innovative IV drug safety technology and fund raising plans on April 9 at the 11th Annual C21 BioVentures conference. Produced by Technology Vision Group LLC and hosted by BayBio, C21 will be held from April 7-9 2009, at the Meritage Resort in Napa, California. C21 is one of the most important meetings for private life science companies looking for suitable corporate partners and the industry's top investors. C21 gathers the world's most innovative private life science companies seeking partnering and financing opportunities to present to an audience of pharma and investors. S.E.A. Medical Systems is very pleased to be presenting at this premier investment conference which offers us an unmatched opportunity for dozens of ideal investor interactions.

S.E.A. Medical Systems, Inc. President and CEO Michael Weickert will outline the company's current status and fund raising plans on March 4th at the "Investment-in-Innovation (In3) West" conference. Medtech Insight, a division of Windhover Conferences and a leading provider of business information for the medical device industry, is hosting the "Investment In Innovation (In3) West" conference, being held March 2-4, 2009 at The Palazzo Resort Hotel and Casino in Las Vegas, NV. Nearly 50 companies will present on the In3 West stage in total. It is a do-not-miss event for those looking to partner, invest and network with the most promising young medical technology companies on course to impact the worldwide med device market. Investment-in-Innovation (In3) conferences are the premier forums worldwide for senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising medical technology companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Conference details.

S.E.A. Medical Systems was recently profiled in a section of the Silicon Valley/San Jose Business Journal called "The Pitch", which features companies recently receiving or currently seeking funding. The on line and print versions described the company's business, how SEA Medical will make money, the businesses we could disrupt, the management team, the advisors, the money being sought and the market size being pursued. Both versions also featured a photo showing the company's Safety Sensor System and the CEO. (full story)

Fact Sheet Posted
SEA Medical Fact Sheet (PDF)

During the two-day event more than 45 venture capitalists from such acclaimed firms as Alloy Ventures, Asset Management Company, ATV Capital, Benchmark Capital, Bessemer Venture Partners, Canaan Partners, Opus Capital, Draper Investment Company, North Bridge Venture Partners, Storm Ventures, Sofinnova Ventures, and Scale Venture Partners among many others, as well as angel investors, were judging the pre-selected 21 (out of the 60 initially submitted) presentations of the high-tech companies. The Panel of Judges named Unified Color Technologies, LLC, a developer of the next generation digital imagery platform technology, as the most promising innovative company of the year. SEA Medical Systems, Inc., a developer of a sensor system that makes intravenous drug delivery safer for patients, and Imajet Communications, Inc., a developer of a new platform for distributed video communications, were named the first and second runners-up respectively. (full text)